Oreste Mora

Patient-Reported Outcomes of Patients With Advanced Biliary Tract Cancers Receiving Gemcitabine Plus Capecitabine: A Multicenter, Phase II Trial of the Swiss Group for Clinical Cancer Research

Dieter Koeberle, Piercarlo Saletti, Markus Borner et al. · Journal of Clinical Oncology · 2008 · 72 citations

Medicine, Oncology, Pharmacology +17

Prognosis of Acute Myeloid Leukemia in the General Population: Data from Southern Switzerland

Erika Lerch, Vittoria Espeli, Emanuele Zucca et al. · Tumori Journal · 2009 · 33 citations

Medicine, Hematology, Oncology +14

A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function

Marco Siano, Erika Lerch, Laura Negretti et al. · Clinical Cancer Research · 2008 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System

Ilenia Mascherona, Caterina Maggioli, Maira Biggiogero et al. · Case Reports in Hepatology · 2020 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17